ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

TBIO Telesis Bio Inc

0.3557
-0.0053 (-1.47%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Telesis Bio Inc TBIO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0053 -1.47% 0.3557 08:59:29
始値 安値 高値 終値 前日終値
0.3502 0.3105 0.36 0.3557 0.361
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1822:00GLOBETelesis Bio Inc. announces strategic focus on game-changing..
2024/3/2905:05GLOBETelesis Bio Reports Fourth Quarter and Full Year 2023..
2024/3/0608:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0608:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0608:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0110:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0110:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2707:00EDGAR2Form 8-K - Current report
2024/2/2623:15GLOBETelesis Bio Announces Select Preliminary Fourth Quarter..
2023/12/0107:00EDGAR2Form 8-K - Current report
2023/11/1406:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:32EDGAR2Form 8-K - Current report
2023/11/1406:22GLOBETelesis Bio Reports Third Quarter 2023 Financial Results
2023/11/1007:00EDGAR2Form 8-K - Current report
2023/11/0723:00GLOBETelesis Bio to Report Third Quarter Financial Results on..
2023/11/0401:00GLOBETelesis Bio Announces Commercial Release of Cell-free..
2023/10/2505:30EDGAR2Form 8-K - Current report
2023/9/2904:48GLOBETelesis Bio Announces Commercial Release of BioXp® NGS..
2023/9/2306:00EDGAR2Form 8-K - Current report
2023/8/3005:05GLOBETelesis Bio Appoints William J. Kullback Chief Financial..
2023/8/3005:02EDGAR2Form 8-K - Current report
2023/8/1119:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:17EDGAR2Form 8-K - Current report
2023/8/1105:05GLOBETelesis Bio Reports Second Quarter 2023 Financial Results
2023/8/0413:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/0406:00GLOBETelesis Bio to Report Second Quarter Financial Results on..
2023/7/2806:28EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/7/0805:01EDGAR2Form 8-K - Current report
2023/6/0822:05GLOBETelesis Bio to Present at Jefferies Healthcare Conference..
2023/6/0616:00GLOBETelesis Bio to Present at Antibody Engineering and..
2023/6/0606:30GLOBETelesis Bio Announces Closing of $28.0 Million Private..
2023/6/0106:29GLOBETelesis Bio Secures Financing of $28.0 Million
2023/5/2322:00GLOBETelesis Bio to Present at SynBioBeta 2023
2023/5/2301:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
2023/5/1823:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
2023/5/1522:00GLOBETelesis Bio to Present at Protein Engineering Summit (PEGS..
2023/5/1205:05GLOBETelesis Bio Reports First Quarter 2023 Financial Results

最近閲覧した銘柄

Delayed Upgrade Clock